Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.

Ailani, Jessica; McAllister, Peter; Winner, Paul K; Chakhava, George; Josiassen, Mette Krog; Lindsten, Annika; Sperling, Bjørn; Ettrup, Anders; Cady, Roger

Ailani, Jessica; McAllister, Peter; Winner, Paul K; Chakhava, George; Josiassen, Mette Krog; Lindsten, Annika; Sperling, Bjørn; Ettrup, Anders; Cady, Roger.

Afiliação

Ailani J; Department of Neurology, Georgetown University Hospital, Washington, DC, USA.
McAllister P; New England Institute for Neurology and Headache, Stamford, CT, USA.
Winner PK; Palm Beach Headache Center, West Palm Beach, FL, USA.
Chakhava G; Georgian Association of Medical Specialties, Multiprofile Clinic Consilium Medulla, D.Tvildiani Medical University, Tbilisi, Georgia.
Josiassen MK; H. Lundbeck A/S, Copenhagen, Denmark.
Lindsten A; H. Lundbeck A/S, Copenhagen, Denmark.
Sperling B; H. Lundbeck A/S, Copenhagen, Denmark.
Ettrup A; H. Lundbeck A/S, Copenhagen, Denmark.
Cady R; Lundbeck LLC, Deerfield, IL, USA. rcady@rkconsults.com.

BMC Neurol ; 23(1): 318, 2023 Sep 06.

Article em En | MEDLINE | ID: mdl-37674117

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Revista: BMC Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google